Finvest
ALHC Healthcare · Medicare Advantage · Growth · Health insurance · Thesis updated July 12, 2026

Fast Medicare growth, with regulatory tripwires

01 Running thesis

Growth is proving out, but not cheap

Alignment is one of the clearer growth stories in Medicare Advantage. It added members at a fast clip, improved its Medical Benefits Ratio to 88.2% in Q1 2026, and turned a prior-year net loss into $11.4 million of net income. That matters because health plans can grow fast and still lose money if medical costs run hot.

The bull case rests on execution. Management says its AVA platform now auto-adjudicates more than 60% of claims, up from less than 15% a year earlier. In plain English, more claims are processed without as much manual work. That can help selling, general, and administrative costs scale better as membership grows.

The bear case is also real. Medicare Advantage is competitive, and CMS rules can change how care is classified and paid. In Q1 2026, a CMS rule change tied to the observation determination process pushed inpatient admissions per 1,000 into the high 150s before Alignment fixed its workflow. The issue was resolved within the quarter, but it showed how quickly margins can get squeezed.

Finn's view is balanced. Growth scores very well, but the overall score is only middle of the pack because valuation and sentiment are weaker. For the stock to work, Alignment likely needs to keep growing membership, hit the raised 2026 Adjusted EBITDA guidance of $138 million to $163 million, and avoid a bad surprise from the RADV audit.

Apr 2026Q1 2026 strengthened the thesis. Membership rose 30.9% year over year, revenue rose 33.3%, Adjusted EBITDA grew 88%, and management raised full-year Adjusted EBITDA guidance.
Apr 2026The same quarter also added a cleaner risk case. A CMS rule change caused a temporary inpatient utilization spike into the high 150s admissions per 1,000 before Alignment fixed its workflow.
Feb 2026The 2025 Form 10-K showed strong full-year execution, with health plan membership up 25.0%, earned premium revenue up 46.4%, and MBR improving to 87.5%.
Feb 2026The RADV audit remained an overhang. A September 2025 court ruling created uncertainty about CMS audit methods and timing, and the government appealed.
Oct 2025The initial thesis was built around Alignment's Medicare Advantage growth model, AVA platform, and one-segment senior healthcare business across 45 markets in five states.
02 Business model

A Medicare plan with a software backbone

Alignment makes money mainly by running Medicare Advantage plans for seniors. Medicare Advantage is a private health plan option for people on Medicare. The company receives premiums, then pays doctors, hospitals, pharmacies, and other care costs for its members.

The key spread is simple: premiums in, medical costs out, and operating costs in between. The Medical Benefits Ratio, or MBR, shows how much premium is used to pay medical claims. Alignment's Q1 2026 MBR was 88.2%, a slight improvement from 88.4% a year earlier.

Management calls its model a virtuous cycle. If AVA helps catch health issues earlier and process claims faster, the company can save money. Those savings can be put back into better benefits, which can attract more members.

Where it breaks is also simple. If members use more hospital care than expected, if bids are too aggressive, or if CMS changes payment rules, the savings can disappear. The Q1 2026 inpatient spike was short-lived, but it is the kind of event investors need to watch.

03 Product portfolio

Plans, networks, and AVA

Growth engine

Medicare Advantage HMO plans

HMO plans are a core product. They use tighter provider networks, which can help control medical costs when care management works well.

Growth engine

Medicare Advantage PPO plans

PPO plans give members more provider choice than an HMO. They widen Alignment's appeal, but looser networks can make cost control harder.

Steady

AVA care and claims platform

AVA is the operating system behind the model. Its claims auto-adjudication rate rose above 60% in Q1 2026, from less than 15% a year earlier.

Growth engine

Member benefits and supplemental coverage

Alignment reinvests savings into richer benefits for seniors. Better benefits can help win members, but only if pricing still covers medical costs.

Option

2027 market expansion plans

New markets are a future growth lever. The open question is whether Alignment can enter them with disciplined bids and good unit economics.

Option

ACO REACH participation

Alignment discontinued participation in the ACO REACH model effective December 31, 2025. It is no longer part of the active growth story.

04 Business segments

One reported business

Healthcare services to seniors100%growing fast
Other reportable segments0%flat

Alignment reports one operating and reportable segment: healthcare services to seniors in the United States. As of the latest filings, it offered plans across 45 markets in five states, but it does not report a revenue split by state in the provided segment disclosure.

05 Risk factors

What could break the cycle

Medical costs run too hot

High impact · Medium odds

Alignment's profits depend on keeping medical claims below the premiums it receives. Q1 2026 MBR was 88.2%, which was better than 88.4% a year earlier, but the cushion is still thin. A rise in hospital stays or drug costs could quickly pressure earnings.

We watchWatch the Medical Benefits Ratio each quarter, especially any move back above recent levels.

CMS process changes disrupt operations

Medium impact · Medium odds

A CMS rule change in Q1 2026 changed the observation determination process and caused inpatient admissions per 1,000 to jump into the high 150s. Management fixed the internal workflow by late February, and the impact was included in Q1 results. Still, the episode showed that rule changes can hurt margins even when member health trends have not changed.

We watchWatch inpatient admissions per 1,000 and management comments on CMS rule changes.

RADV audit payback risk

High impact · Medium odds

CMS selected Alignment's California HMO plan for a contract-specific RADV audit for payment year 2019. RADV audits check risk-adjustment payments and can lead to retrospective payment adjustments. A September 2025 court decision vacated the CMS final rule on procedural grounds, and the government appealed, so timing and method are uncertain.

We watchWatch updates on the CMS RADV audit process, court appeal, and any reserve or repayment disclosure.

Competitive bidding pressure

Medium impact · High odds

Medicare Advantage is crowded, and larger insurers can compete hard on benefits, networks, and pricing. Alignment wants to grow membership toward the raised 2026 guidance range of 294,000 to 299,000 members. If it has to bid too aggressively to win members, growth could come with weaker margins.

We watchWatch annual bid commentary, benefit changes, and whether member growth comes with stable MBR.

AVA automation hits a ceiling

Medium impact · Medium odds

The AVA platform is a major part of the operating leverage story. Claims auto-adjudication rising above 60% is a strong proof point, but investors do not yet know the ceiling. If automation stalls, SG&A leverage may slow even if membership keeps growing.

We watchWatch future claims auto-adjudication rates and SG&A as a share of revenue.
06 Quick answers

In one breath

What does Alignment Healthcare do?

Alignment runs Medicare Advantage health plans for seniors. It uses its AVA platform to manage care, process claims, and try to lower medical and operating costs.

Why is ALHC growing so fast?

Membership growth is the main driver. Health plan membership was 284,800 at March 31, 2026, up 30.9% from a year earlier, and Q1 2026 revenue rose 33.3%.

What is the biggest risk for ALHC?

The biggest risk is that medical costs or regulatory changes move faster than the company can adjust. The Q1 2026 inpatient spike tied to a CMS rule change is a clear example.

Is Alignment Healthcare profitable?

In Q1 2026, Alignment reported net income of $11.4 million after a net loss in the prior-year quarter. Adjusted EBITDA was $37.9 million, up 88% year over year.